Your browser doesn't support javascript.
loading
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Gambacorti-Passerini, Carlo B; Donadoni, Carla; Parmiani, Andrea; Pirola, Alessandra; Redaelli, Sara; Signore, Giovanni; Piazza, Vincenzo; Malcovati, Luca; Fontana, Diletta; Spinelli, Roberta; Magistroni, Vera; Gaipa, Giuseppe; Peronaci, Marco; Morotti, Alessandro; Panuzzo, Cristina; Saglio, Giuseppe; Usala, Emilio; Kim, Dong-Wook; Rea, Delphine; Zervakis, Konstantinos; Viniou, Nora; Symeonidis, Argiris; Becker, Heiko; Boultwood, Jacqueline; Campiotti, Leonardo; Carrabba, Matteo; Elli, Elena; Bignell, Graham R; Papaemmanuil, Elli; Campbell, Peter J; Cazzola, Mario; Piazza, Rocco.
Afiliação
  • Gambacorti-Passerini CB; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy; Hematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy;
  • Donadoni C; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Parmiani A; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Pirola A; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Redaelli S; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Signore G; Center for Nanotechnology Innovation @NEST, Istituto Italiano di Tecnologia, Pisa, Italy;
  • Piazza V; Center for Nanotechnology Innovation @NEST, Istituto Italiano di Tecnologia, Pisa, Italy;
  • Malcovati L; Department of Hematology Oncology, Fondazione Istituto di ricovero e cura a carattere scientifico Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Fontana D; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Spinelli R; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Magistroni V; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Gaipa G; Tettamanti Research Center, Pediatric Clinic University of Milano-Bicocca, Monza, Italy;
  • Peronaci M; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
  • Morotti A; Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Turin, Italy;
  • Panuzzo C; Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Turin, Italy;
  • Saglio G; Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Turin, Italy;
  • Usala E; S.C. di Ematologia e Centro Trapianti di Cellule Staminali Emopoietiche, Dipartimento di Oncologia Medica, Ospedale Oncologico "Armando Businco," Cagliari, Italy;
  • Kim DW; Department of Hematology, Catholic University, Seoul, Korea;
  • Rea D; Service d'Hématologie adulte, Hôpital Saint-Louis, Paris, France;
  • Zervakis K; 1st Department of Internal Medicine, Hematology Unit, LAIKON Hospital, National and Kapodistrian University of Athens, Athens, Greece;
  • Viniou N; 1st Department of Internal Medicine, Hematology Unit, LAIKON Hospital, National and Kapodistrian University of Athens, Athens, Greece;
  • Symeonidis A; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece;
  • Becker H; Universitätsklinikum Freiburg, Innere Medizin I-Hämatologie, Onkologie, und Stammzelltransplantation, Freiburg, Germany;
  • Boultwood J; Leukaemia and Lymphoma Research Molecular Hematology Unit, John Radcliffe Hospital, Oxford, United Kingdom;
  • Campiotti L; Dipartimento Medicina Clinica e Sperimentale, Università Insubria, Varese, Italy;
  • Carrabba M; Ematologia e Trapianto di Midollo, Istituto di ricovero e cura a carattere scientifico, Ospedale San Raffaele, Milano, Italy;
  • Elli E; Hematology Unit, San Gerardo Hospital, Monza, Italy; and.
  • Bignell GR; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Papaemmanuil E; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Campbell PJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Cazzola M; Department of Hematology Oncology, Fondazione Istituto di ricovero e cura a carattere scientifico Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Piazza R; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy;
Blood ; 125(3): 499-503, 2015 Jan 15.
Article em En | MEDLINE | ID: mdl-25343957
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mielomonocítica Crônica / Fosfotransferases (Aceptor do Grupo Álcool) / Mutação Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mielomonocítica Crônica / Fosfotransferases (Aceptor do Grupo Álcool) / Mutação Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article